期刊文献+

不同营养方式对肝硬化肝癌大鼠肝部分切除术后免疫功能的影响 被引量:3

Effects of different nutritional pathway on immune function in rats with hepatic cirrhosis and hepatoma undergoing partial hepatectomy
下载PDF
导出
摘要 目的探讨不同营养方式对肝硬化肝癌大鼠肝部分切除术后免疫功能的影响。方法将成功建立肝硬化肝癌大鼠模型的大鼠随机分为肠外营养组(PN组)、肠内营养组(EN组)、肠内肠外混合营养组(PN+EN组,PN和EN供能各50%)、常规经口饮食组(R0组),应用Higgins法行大鼠肝部分切除术,术后给予上述不同营养方式1W,分别于术前、术后第1、3、7、14天:ELISA法检测大鼠血清的IL-2、IL-6、INF—γ、TNF-α;流式细胞仪检测全血的CD3、CD4、CD8、CD4/CD8、NK;单纯琼脂扩散法检测血浆IgA、IgM、IgG。结果PN组营养对大鼠术前、术后免疫功能无明显影响(P〉0.05);EN组营养增强大鼠术后免疫功能(P〈0.05);PN+EN组营养同样能增强大鼠术后免疫功能(P〈0.05),但效果差于EN组(P〈0.05)。结论EN营养可明显增强大鼠术后免疫功能,PN+EN营养次之,PN无明显免疫增强功能。 Objective To explore the effects of different nutritional pathway on immune function in rats with hepatic cirrhosis and hepatoma undergoing partial hepatectomy. Methods The successfully established model of rats with hepatic cirrhosis and hepatoma undergoing partial hepatectomy by Higgins'skill were randomly divided into parenteral nutrition group (PN group), enteral nutrition group (EN grooup), PN+EN group and routinely oral group (RO group).The serum levels of IL-2, IL-6, INF- γ,TNF- α and the percent of CD3^+,CD4^+,CD8^+,NK, CD4^+/ CD8^+ and the plasma levels of IgA, IgM, IgG were observed respectively at different times of perioperation. Results There were no differences in immune function between PN group and RO group (P〉0. 05), but signifcant differences between EN group and PN group (P〈0.05). There were also differences in immue function between PN+EN group and PN group (P〈0.05). Conclusion The nutritional pathway of PN+EN nutrition can enhance immune function in rats with hepatic cirrhosis and hepatoma undergoing partial haptectomy and the higher effects in enteral nutrition, but no effects in parenteral nutrition.
出处 《国际医药卫生导报》 2008年第15期13-17,共5页 International Medicine and Health Guidance News
基金 深圳市宝安区科技计划项目(编号:2007021)
关键词 肝硬化 肝癌 切除术 营养方式 免疫功能 Hepatic cirrhosis Hepatoma Hepateetomy Nutritional pathway Immune function
  • 相关文献

参考文献6

  • 1梁力建,赖佳明,罗时敏.术后应用肠外营养对肝细胞癌合并肝硬化病人的影响[J].中华肝胆外科杂志,2005,11(11):758-762. 被引量:5
  • 2Moriwaki H, Tajika M, Miwa Y, et al. Nutritional pharmeotherapy of chronic liver disease: from support of liver failure to prevention of liver cancer[J]. Gastroenterology, 2000,35:13-17 被引量:1
  • 3唐朝晖,胡元龙.胃肠肿瘤病人术后早期肠内营养支持对机体细胞免疫的影响[J].中国临床营养杂志,1999,7(4):165-167. 被引量:34
  • 4Schanden Mcclare SV, Lowne CC, Snider HI,et al. Inmmunonutrition and enteral hyperalimentation of critically ill pateints [J].Dig Dis Sci, 2002,37: 1153- 1159 被引量:1
  • 5Dinney CP, Bielenberg DR, Perrotte P, et al. Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration [J]. Cancer Res, 1998, 58: 808-814 被引量:1
  • 6Balasubram aniyan V, Shukla R, Murugaiyan G, et al. Mouse recombinant leptin protects human hepatoma HepG2 against apoptosis, TNF-alpha respone and oxida-tive stress induced by the hepatotoxinethanol [J].Biochim Biophys Acta, 2007, 1770: 1136-1144 被引量:1

二级参考文献14

  • 1靳大勇,吴肇汉.胃肠癌手术前营养支持与肿瘤生长[J].中国实用外科杂志,1995,15(6):336-338. 被引量:31
  • 2Caufriez A, Reding P, Urbain D, et al. Insulin-like growth factor I: a good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis. J Endocrinol Invest, 1991, 14: 317-321. 被引量:1
  • 3Shaarawy M, Fikry MA, Massoud BA, et al. Insulin-like growth factor binding protein-3 : a novel biomarker for the assessment of the synthetic capacity of hepatocytes in liver cirrhosis. J Clin Endocrinol Metab, 1998, 83: 3316-3319. 被引量:1
  • 4Moschos SJ, Mantzoros CS. The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology, 2002, 63: 317-322. 被引量:1
  • 5Blanck A, Assdaw-Redda Y, Eriksson LC, et al. Growth hormone administration after treatment in the resistant hepatocyte model does not affect progression of rat liver carcinogenesis.Cancer Lett, 1994, 79: 193-198. 被引量:1
  • 6Levinovitz A, Husman B, Eriksson LC, et al. Decreased expression of the growth hormone receptor and growth hormone binding protein in rat liver nodules. Mol Carcinog, 1990,3:157-164. 被引量:1
  • 7Tacke J, Bolder U, Herrmann A, et al. Long-term risk of gastrointestinal tumor recurrence after postoperative treatment with recombinant human growth hormone. J Parenter Enteral Nutr,2000, 24: 140-144. 被引量:1
  • 8Yamasaki H, Prager D, Melmed S. Structure-function of human insulin-like growth factor-I receptor: a discordance of somatotroph internalization and signaling. Mol Endocrinol, 1993, 7: 681-685. 被引量:1
  • 9Minuto F, Barreca A, Adami GF, et al. Insulin-like growth factor-I in human malnutrition., relationship with some body composition and nutritional parameters. J Parenter Enteral Nutr, 1989,13: 392-396. 被引量:1
  • 10B. Roth,M. Ekelund,B. -G. Fan,I. H?gerstrand,P. Nilsson-Ehle. Lipid deposition in kupffer cells after parenteral fat nutrition in rats: A biochemical and ultrastructural study[J] 1996,Intensive Care Medicine(11):1224~1231 被引量:1

共引文献37

同被引文献23

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部